OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Diagnostic and Prognostic Utility of PD-1 In B Cell Lymphomas
Simone Muenst, Sylvia Hoeller, Niels Willi, et al.
Disease Markers (2010) Vol. 29, Iss. 1, pp. 47-53
Open Access | Times Cited: 90
Simone Muenst, Sylvia Hoeller, Niels Willi, et al.
Disease Markers (2010) Vol. 29, Iss. 1, pp. 47-53
Open Access | Times Cited: 90
Showing 1-25 of 90 citing articles:
Overview of multiplex immunohistochemistry/immunofluorescence techniques in the era of cancer immunotherapy
Wei Tan, Sanjna Nilesh Nerurkar, Hai Yun Cai, et al.
Cancer Communications (2020) Vol. 40, Iss. 4, pp. 135-153
Open Access | Times Cited: 482
Wei Tan, Sanjna Nilesh Nerurkar, Hai Yun Cai, et al.
Cancer Communications (2020) Vol. 40, Iss. 4, pp. 135-153
Open Access | Times Cited: 482
Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma
Junichi Kiyasu, Hiroaki Miyoshi, Akie Hirata, et al.
Blood (2015) Vol. 126, Iss. 19, pp. 2193-2201
Open Access | Times Cited: 425
Junichi Kiyasu, Hiroaki Miyoshi, Akie Hirata, et al.
Blood (2015) Vol. 126, Iss. 19, pp. 2193-2201
Open Access | Times Cited: 425
Genetic absence of PD-1 promotes accumulation of terminally differentiated exhausted CD8+ T cells
Pamela M. Odorizzi, Kristen E. Pauken, Michael Paley, et al.
The Journal of Experimental Medicine (2015) Vol. 212, Iss. 7, pp. 1125-1137
Open Access | Times Cited: 401
Pamela M. Odorizzi, Kristen E. Pauken, Michael Paley, et al.
The Journal of Experimental Medicine (2015) Vol. 212, Iss. 7, pp. 1125-1137
Open Access | Times Cited: 401
Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL
Wei Ding, Betsy LaPlant, Timothy G. Call, et al.
Blood (2017) Vol. 129, Iss. 26, pp. 3419-3427
Open Access | Times Cited: 381
Wei Ding, Betsy LaPlant, Timothy G. Call, et al.
Blood (2017) Vol. 129, Iss. 26, pp. 3419-3427
Open Access | Times Cited: 381
PD-1 expression and clinical PD-1 blockade in B-cell lymphomas
Zijun Y. Xu‐Monette, Jianfeng Zhou, Ken H. Young
Blood (2017) Vol. 131, Iss. 1, pp. 68-83
Open Access | Times Cited: 368
Zijun Y. Xu‐Monette, Jianfeng Zhou, Ken H. Young
Blood (2017) Vol. 131, Iss. 1, pp. 68-83
Open Access | Times Cited: 368
The immune system and cancer evasion strategies: therapeutic concepts
Simone Muenst, Heinz Läubli, Savas D. Soysal, et al.
Journal of Internal Medicine (2016) Vol. 279, Iss. 6, pp. 541-562
Open Access | Times Cited: 262
Simone Muenst, Heinz Läubli, Savas D. Soysal, et al.
Journal of Internal Medicine (2016) Vol. 279, Iss. 6, pp. 541-562
Open Access | Times Cited: 262
PD-1 and CD103 Are Widely Coexpressed on Prognostically Favorable Intraepithelial CD8 T Cells in Human Ovarian Cancer
John R. Webb, Katy Milne, Brad H. Nelson
Cancer Immunology Research (2015) Vol. 3, Iss. 8, pp. 926-935
Closed Access | Times Cited: 180
John R. Webb, Katy Milne, Brad H. Nelson
Cancer Immunology Research (2015) Vol. 3, Iss. 8, pp. 926-935
Closed Access | Times Cited: 180
Upregulation of PD-L1 and APE1 is associated with tumorigenesis and poor prognosis of gastric cancer
Yi Qing, Qing Li, Tao Ren, et al.
Drug Design Development and Therapy (2015), pp. 901-901
Open Access | Times Cited: 162
Yi Qing, Qing Li, Tao Ren, et al.
Drug Design Development and Therapy (2015), pp. 901-901
Open Access | Times Cited: 162
Follicular Lymphomas in Children and Young Adults
Qingyan Liu, Itziar Salaverría, Stefania Pittaluga, et al.
The American Journal of Surgical Pathology (2012) Vol. 37, Iss. 3, pp. 333-343
Open Access | Times Cited: 154
Qingyan Liu, Itziar Salaverría, Stefania Pittaluga, et al.
The American Journal of Surgical Pathology (2012) Vol. 37, Iss. 3, pp. 333-343
Open Access | Times Cited: 154
Evaluation of the diagnostic and prognostic value of PDL1 expression in Hodgkin and B-cell lymphomas
Thomas Menter, Andrea Bodmer-Haecki, Stephan Dirnhofer, et al.
Human Pathology (2016) Vol. 54, pp. 17-24
Closed Access | Times Cited: 154
Thomas Menter, Andrea Bodmer-Haecki, Stephan Dirnhofer, et al.
Human Pathology (2016) Vol. 54, pp. 17-24
Closed Access | Times Cited: 154
Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL
Ziju Y. Xu-Monette, Min Xiao, Qingyan Au, et al.
Cancer Immunology Research (2019) Vol. 7, Iss. 4, pp. 644-657
Open Access | Times Cited: 133
Ziju Y. Xu-Monette, Min Xiao, Qingyan Au, et al.
Cancer Immunology Research (2019) Vol. 7, Iss. 4, pp. 644-657
Open Access | Times Cited: 133
PD-1 expression defines two distinct T-cell sub-populations in follicular lymphoma that differentially impact patient survival
Zhengke Yang, D M Grote, S C Ziesmer, et al.
Blood Cancer Journal (2015) Vol. 5, Iss. 2, pp. e281-e281
Open Access | Times Cited: 131
Zhengke Yang, D M Grote, S C Ziesmer, et al.
Blood Cancer Journal (2015) Vol. 5, Iss. 2, pp. e281-e281
Open Access | Times Cited: 131
Mechanisms of PD-1/PD-L1 expression and prognostic relevance in non-Hodgkin lymphoma: a summary of immunohistochemical studies
Pauline Gravelle, Barbara Burroni, Sarah Péricart, et al.
Oncotarget (2017) Vol. 8, Iss. 27, pp. 44960-44975
Open Access | Times Cited: 95
Pauline Gravelle, Barbara Burroni, Sarah Péricart, et al.
Oncotarget (2017) Vol. 8, Iss. 27, pp. 44960-44975
Open Access | Times Cited: 95
Tumor Microenvironment in Diffuse Large B-Cell Lymphoma: Role and Prognosis
Alexandra Cioroianu, Patricia Irina Stinga, Liana Sticlaru, et al.
Analytical Cellular Pathology (2019) Vol. 2019, pp. 1-9
Open Access | Times Cited: 78
Alexandra Cioroianu, Patricia Irina Stinga, Liana Sticlaru, et al.
Analytical Cellular Pathology (2019) Vol. 2019, pp. 1-9
Open Access | Times Cited: 78
The PD-1/PD-L1 pathway: biological background and clinical relevance of an emerging treatment target in immunotherapy
Simone Muenst, Savas D. Soysal, Alexandar Tzankov, et al.
Expert Opinion on Therapeutic Targets (2014) Vol. 19, Iss. 2, pp. 201-211
Closed Access | Times Cited: 94
Simone Muenst, Savas D. Soysal, Alexandar Tzankov, et al.
Expert Opinion on Therapeutic Targets (2014) Vol. 19, Iss. 2, pp. 201-211
Closed Access | Times Cited: 94
Follicular helper T cells: implications in neoplastic hematopathology
Philippe Gaulard, Laurence de Leval
Seminars in Diagnostic Pathology (2011) Vol. 28, Iss. 3, pp. 202-213
Open Access | Times Cited: 92
Philippe Gaulard, Laurence de Leval
Seminars in Diagnostic Pathology (2011) Vol. 28, Iss. 3, pp. 202-213
Open Access | Times Cited: 92
An automated staining protocol for seven-colour immunofluorescence of human tissue sections for diagnostic and prognostic use
Jeffrey Chun Tatt Lim, Joe Yeong, Chun Jye Lim, et al.
Pathology (2018) Vol. 50, Iss. 3, pp. 333-341
Closed Access | Times Cited: 76
Jeffrey Chun Tatt Lim, Joe Yeong, Chun Jye Lim, et al.
Pathology (2018) Vol. 50, Iss. 3, pp. 333-341
Closed Access | Times Cited: 76
Programmed cell death-1 inhibition in lymphoma
Eliza A. Hawkes, Andrew Grigg, Geoff Chong
The Lancet Oncology (2015) Vol. 16, Iss. 5, pp. e234-e245
Closed Access | Times Cited: 67
Eliza A. Hawkes, Andrew Grigg, Geoff Chong
The Lancet Oncology (2015) Vol. 16, Iss. 5, pp. e234-e245
Closed Access | Times Cited: 67
Lymphocyte-to-monocyte ratio is associated with prognosis of diffuse large B-cell lymphoma: correlation with CD163 positive M2 type tumor-associated macrophages, not PD-1 positive tumor-infiltrating lymphocytes
Jingxuan Wang, Kun Gao, Wanting Lei, et al.
Oncotarget (2016) Vol. 8, Iss. 3, pp. 5414-5425
Open Access | Times Cited: 67
Jingxuan Wang, Kun Gao, Wanting Lei, et al.
Oncotarget (2016) Vol. 8, Iss. 3, pp. 5414-5425
Open Access | Times Cited: 67
Mass Cytometry Analysis Reveals that Specific Intratumoral CD4+ T Cell Subsets Correlate with Patient Survival in Follicular Lymphoma
Zhi-Zhang Yang, Hyo Jin Kim, José C. Villasboas, et al.
Cell Reports (2019) Vol. 26, Iss. 8, pp. 2178-2193.e3
Open Access | Times Cited: 67
Zhi-Zhang Yang, Hyo Jin Kim, José C. Villasboas, et al.
Cell Reports (2019) Vol. 26, Iss. 8, pp. 2178-2193.e3
Open Access | Times Cited: 67
PD-1 Expression in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Large B-cell Richter Transformation (DLBCL-RT)
Rong He, Wei Ding, David S. Viswanatha, et al.
The American Journal of Surgical Pathology (2018) Vol. 42, Iss. 7, pp. 843-854
Closed Access | Times Cited: 63
Rong He, Wei Ding, David S. Viswanatha, et al.
The American Journal of Surgical Pathology (2018) Vol. 42, Iss. 7, pp. 843-854
Closed Access | Times Cited: 63
Understanding Immune Evasion and Therapeutic Targeting Associated with PD-1/PD-L1 Pathway in Diffuse Large B-cell Lymphoma
Gyung Hyuck Ko, Byeong-Bae Park, Jieun Uhm
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 6, pp. 1326-1326
Open Access | Times Cited: 63
Gyung Hyuck Ko, Byeong-Bae Park, Jieun Uhm
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 6, pp. 1326-1326
Open Access | Times Cited: 63
Prognostic and clinicopathological significance of PD-1/PD-L1 expression in the tumor microenvironment and neoplastic cells for lymphoma
Mixue Xie, Xianbo Huang, Xiujin Ye, et al.
International Immunopharmacology (2019) Vol. 77, pp. 105999-105999
Closed Access | Times Cited: 55
Mixue Xie, Xianbo Huang, Xiujin Ye, et al.
International Immunopharmacology (2019) Vol. 77, pp. 105999-105999
Closed Access | Times Cited: 55
Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorders
Fanny Beltzung, Nicolás Ortonne, Laura Pelletier, et al.
The American Journal of Surgical Pathology (2020) Vol. 44, Iss. 7, pp. 862-872
Closed Access | Times Cited: 55
Fanny Beltzung, Nicolás Ortonne, Laura Pelletier, et al.
The American Journal of Surgical Pathology (2020) Vol. 44, Iss. 7, pp. 862-872
Closed Access | Times Cited: 55
Immune checkpoint inhibitors in lymphoma: challenges and opportunities
Haris Hatic, Devi Sampat, Gaurav Goyal
Annals of Translational Medicine (2021) Vol. 9, Iss. 12, pp. 1037-1037
Open Access | Times Cited: 51
Haris Hatic, Devi Sampat, Gaurav Goyal
Annals of Translational Medicine (2021) Vol. 9, Iss. 12, pp. 1037-1037
Open Access | Times Cited: 51
